AList4Research (@AList4Research) header
AList4Research (@AList4Research) profile picture

Our Data. Our Voice. Our Future. Accelerating Alzheimer’s Research & Cures by Harnessing Our Collective Insights. https://xitter.gq/t.co/qog2ckgm1T

Joined October 2015
Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)Photo by AList4Research (@AList4Research)
AList4Research retweeted
I talked with @NextAvenue about the impact of #COVID19 on family caregivers, particularly caregivers of color. Part 1 of a 🧵 nextavenue.org/caregiving-an… #BrainHealthEquity
1
1
1
5
The holidays will be different this year, and if you are a #caregiver to a loved one with #Alzheimers, chances are you will feel this more acutely than others. UsA2 reminds our #caregivers that you are not alone. You have Us. #FamilyCaregiversMonth. bit.ly/2UJQMdW
The AD-PACE initiative is the first of its kind to align patient and #caregiver preferences for the treatment of #Alzheimers and determine what matters most to those impacted by the disease. #AlzheimersAwarenessMonth #FamilyCaregiversMonth @LundbeckUS bit.ly/35Gm384
2
3
We are pleased to present our latest @UsAgainstAlz research on the impact of agitation in #dementia this week at @CTADconference! #CTAD20
Agitation in #Alzheimers disease and dementia is associated with many negative outcomes, not least of which is #caregiver burden — including comorbidities such as insomnia and hypertension. UsA2's A-LIST research w/ @OtsukaUS explores these impacts: bit.ly/34RWzUD
1
1
In our latest survey, A-LIST members told us how they imagine life changing with a #COVID19 vaccine. Answers are a mix of skeptical, optimistic & hopeful for a return to normalcy.
No other community has been hit harder during #COVID19 than #Alzheimers and #dementia patients, especially in long-term care. UsA2's latest blog post explores how life will change for us all once a #COVID19 vaccine becomes available. bit.ly/3iWOli4
1
60% of the #Alzheimers community is willing to get a #COVID19 vaccine when one becomes available, nearly double the percentage of the general population polled in a recent national survey. @Being_Patient_ @cannoneyes bit.ly/2SAq6vd
2
5
We are honored to be part of this team with Dr. Griffin, and researchers from @UMassBoston, @usuCEHS & @PublicHealthUMN, as well as our @UsAgainstAlz colleagues @jason_r_DC & @SMonroe2020
This Post is from an account that no longer exists. Learn more
1
3
UsA2's A-LIST survey found 2/3rds of #caregivers have observed cognitive decline in loved ones since the pandemic started. Thank you @mindingourelder for helping to answer, "What can we do?" to reunite families struggling with isolation. bit.ly/3iQopp7
2
5
We are very fortunate that Terry leads this work as PI of @UsAgainstAlz A-LIST What Matters Most Insights study. Thank you to @cohenbioscience for highlighting this work that shines a glaring light on the terrible impact of #Covid on our community.
This Post is from an account that no longer exists. Learn more
Excellent Town Hall discussion planned for how our society can do better for those with #dementia now and in the future. Sign up for updates!
UsA2 is committed to accelerating an end to #Alzheimers. Register for the upcoming national summit and take action against #Alzheimers today. #WorldAlzheimersDay usagainstalzheimers.org/even…
There are many misconceptions and stigma related to #dementia but @Traceylind @OnPlutoOB & Daisy Duarte are shining a light on how living life to the fullest is possible. bit.ly/331m9Vn
Communities of color face barriers to better brain health that must be addressed. The Center for #BrainHealthEquity will bring needed resources to these communities bc prevention is critical. bit.ly/31KbvBD
#Alzheimers #caregivers are facing extreme levels of stress due to #COVID19. "Clinicians have to be prepared to meet the needs of both the patient and the caregiver,” said Dr. Angela M. Allen on #COVID19 impacts on the #Alzheimer community. bit.ly/33dY4fq
1
3
The #Alz patient & #caregiver must have a voice in health outcomes. UsA2's research is a crucial step forward to ensure drug development for #Alzheimers and related #dementias address what's most important to those living with these diseases. bit.ly/3gi2XYU
#ICYMI: Watch our video to hear from dementia caregivers how #COVID19 related restrictions in long-term care facilities have affected their ability to care for loved ones living with #Alzheimers. @AList4Research
3
4
#GoldieSmithByrd: "Fewer than 10% of clinical trial participants come from African American, Latino and Asian populations." Our #ADPACE initiative will change that. @WFSOMMACHE